NYSE:A - Agilent Technologies Stock Price, Price Target & More

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies announced a quarterly dividend on Wednesday, May 16th. Stockholders of record on Tuesday, July 3rd will be paid a dividend of $0.149 per share on Wednesday, July 25th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date of this dividend is Monday, July 2nd. View Agilent Technologies' Dividend History.

Agilent Technologies Inc (NYSE:A) issued its earnings results on Monday, May, 14th. The medical research company reported $0.65 earnings per share for the quarter, topping analysts' consensus estimates of $0.64 by $0.01. The medical research company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The business's quarterly revenue was up 9.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.58 earnings per share. View Agilent Technologies' Earnings History.

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for Agilent Technologies.

Agilent Technologies updated its FY18 earnings guidance on Monday, May, 14th. The company provided EPS guidance of $2.63-2.67 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.70. The company issued revenue guidance of $4.85-4.87 billion, compared to the consensus revenue estimate of $4.92 billion.Agilent Technologies also updated its Q3 guidance to $0.61-0.63 EPS.

12 Wall Street analysts have issued 12-month price targets for Agilent Technologies' stock. Their predictions range from $60.73 to $91.00. On average, they anticipate Agilent Technologies' stock price to reach $72.8108 in the next twelve months. View Analyst Ratings for Agilent Technologies.

Some companies that are related to Agilent Technologies include Illumina (ILMN), Waters (WAT), Mettler-Toledo International (MTD), Bio-Rad Laboratories, Inc. Class A Common Stock (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), PerkinElmer (PKI), Integra Lifesciences (IART), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM) and Harvard Bioscience (HBIO).

News headlines about A stock have been trending somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Agilent Technologies earned a news sentiment score of 0.17 on Accern's scale. They also gave news articles about the medical research company an impact score of 46.29 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Agilent Technologies' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.82%), OppenheimerFunds Inc. (1.44%), JPMorgan Chase & Co. (1.24%), Cantillon Capital Management LLC (1.20%), Northern Trust Corp (1.19%) and American Century Companies Inc. (1.09%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Victory Capital Management Inc., Cantillon Capital Management LLC, PNC Financial Services Group Inc., State of Tennessee Treasury Department, Select Equity Group L.P., Swiss National Bank and Sei Investments Co.. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Patrick Kaltenbach and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

A stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., OppenheimerFunds Inc., Old Mutual Global Investors UK Ltd., Royal Bank of Canada, Echo Street Capital Management LLC, Wells Fargo & Company MN, Natixis and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Agilent Technologies.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of A stock can currently be purchased for approximately $62.79.

Agilent Technologies has a market capitalization of $20.09 billion and generates $4.47 billion in revenue each year. The medical research company earns $684 million in net income (profit) each year or $2.36 on an earnings per share basis. Agilent Technologies employs 13,500 workers across the globe.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]